HAEMATOLOGICAL MALIGNANCY
Clinical trials for HAEMATOLOGICAL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HAEMATOLOGICAL MALIGNANCY trials appear
Sign up with your email to follow new studies for HAEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer drug capmatinib tested on rare tumors – could it be a new lifeline?
Disease control Recruiting nowThis study tests capmatinib, a drug already approved for certain lung cancers, in adults with other rare cancers that have specific MET gene changes. About 30 participants will receive the drug to see if their tumors shrink or stop growing for at least 24 weeks. The goal is to fi…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 17, 2026 02:59 UTC
-
Could a lung cancer drug work for other rare cancers? new trial aims to find out.
Disease control Recruiting nowThis study tests a drug called entrectinib, already approved for certain lung and solid tumors, in people with rare cancers that have a specific genetic change called ROS1 fusion. About 30 adults, teens, and children with these rare cancers will receive the drug. Researchers will…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Could a lung cancer drug treat rare tumors? new trial seeks answers
Disease control Recruiting nowThis study tests alectinib, a drug already approved for some lung cancers, in patients with rare cancers that have an ALK gene change. About 30 adults and children with ALK-positive cancers will receive alectinib to see if it shrinks tumors or stops them from growing. The goal is…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Breast cancer drugs may fight rare tumors with HER2 changes
Disease control Recruiting nowThis study tests two drugs, trastuzumab and pertuzumab, already approved for breast cancer, in people with other rare cancers that have a specific genetic change called HER2 amplification or mutation. About 30 adults and children with various tumor types will receive the drug com…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Could a melanoma drug combo work for other rare cancers?
Disease control Recruiting nowThis study tests two drugs, vemurafenib and cobimetinib, already approved for melanoma, in adults with other rare cancers that have a specific BRAF V600 gene change. About 30 people will take the drugs to see if their tumors shrink or stop growing. The goal is to find new uses fo…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New hope for blood cancer patients: experimental drug CCS1477 enters trials
Disease control Recruiting nowThis study tests a new drug called CCS1477 (inobrodib) in people with advanced blood cancers like leukemia, lymphoma, and multiple myeloma. The goal is to see if the drug is safe and can help control the disease. About 250 participants who have tried standard treatments without s…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: CellCentric Ltd. • Aim: Disease control
Last updated May 05, 2026 11:52 UTC
-
Gene-Guided dosing aims to stop deadly fungal infections in cancer patients
Disease control Recruiting nowThis study tests whether using a patient's genetic information to dose the antifungal drug voriconazole can help more patients reach the right drug level in their blood compared to standard dosing. The trial will enroll about 104 children and adults with blood cancer or fungal in…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE2 • Sponsor: The University of Queensland • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
Could old drugs unlock new cures for rare cancers? DETERMINE trial aims to find out.
Knowledge-focused Recruiting nowThis study tests whether drugs already approved for some cancers can help people with rare cancers or common cancers that have rare genetic changes. It includes adults, teenagers, and children whose cancer has a specific mutation and who have no other standard treatment options. …
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC